Breaking News

Title21 Health Solutions Acquires MyCellHub and Its MES Platform

Expands its ability to connect the advanced therapies ecosystem through digital solutions.

Author Image

By: Charlie Sternberg

Associate Editor

Title21 Health Solutions, a provider of enterprise quality management systems and cell and gene therapy orchestration platforms, has acquired MyCellHub and its advanced manufacturing execution system (MES) platform. Through the acquisition of MyCellHub, Title21 strengthens its position to serve as the data bridge connecting entities across the advanced therapies ecosystem, driving data sharing and transparency and accelerating research and therapy development. Adding a MES platform to its sol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters